Malaysia grants conditional approval for CanSino, J&J Covid-19 vaccines

Malaysia

Malaysia has granted conditional approval for emergency use to the single dose Covid-19 vaccines manufactured by China's CanSino Biologics and US drugmaker Johnson & Johnson, the government said on Tuesday. The Southeast Asian country has been ramping up its vaccination programme, amid a fresh round of lockdowns imposed this month to curb a surge in coronavirus infections. Malaysia would obtain Johnson & Johnson's vaccines via the global COVAX facility backed by the World Health Organization, the health ministry said in a statement. It did not say how many doses it would procure via COVAX. The government has said previously it had secured 3.5 million doses of CanSino's shot, though it has yet to receive any shipments of the vaccine.